Home Your basket
• Myasthenia gravis and oro...
   Price 5.50 €
• IPSEN Foundation meeting:...
   Price 5.50 €
• Moderate leukocyte infilt...
   Price 10.50 €
• Diagnosis of non organic ...
   Price 8.50 €
• Adult laryngeal cavernous...
   Price 5.50 €
• Dehiscence of the anterio...
   Price 8.50 €
• Quality of life evaluatio...
   Price 10.50 €
• Laryngeal pemphigus...
   Price 5.50 €
• Prosthetics gains and sat...
   Price 12.50 €
• Drop weld thermal injurie...
   Price 8.50 €
• Notes on voice and speech...
   Price 8.50 €
• Using the superficial tem...
   Price 10.50 €
• Vocal and behavioral adap...
   Price 10.50 €
• Protruding ears...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Nasal septal abscess: A c...
   Price 5.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• Evaluation of the handica...
   Price 10.50 €
• Cervical cystic lymphangi...
   Price 5.50 €
• Vertical extended hemi cr...
   Price 5.50 €
• "Bamboo nodes" : a clinic...
   Price 8.50 €
• The cost of running a mul...
   Price 5.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• The monaural pseudo-stere...
   Price 8.50 €
• Guidelines for the clinic...
   Price 12.50 €
• Life after total laryngec...
   Price 8.50 €
• Free sorting task of spee...
   Price 10.50 €
• Assumptions in surgical t...
   Price 8.50 €
• The use of ultrasound eva...
   Price 8.50 €
• Lengthening temporalis my...
   Price 10.50 €
• Endoscopic medialization ...
   Price 8.50 €
• Predictive factors for su...
   Price 15.00 €
• The «intra-cordal polyp»:...
   Price 5.50 €
• When some clinical cases ...
   Price 8.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Side-to-end hypoglossal-f...
   Price 10.50 €
• Orbital apex syndrome fol...
   Price 10.50 €
• Evaluation of the efficie...
   Price 10.50 €
• Papillary thyroid microca...
   Price 10.50 €
• Combined transoral and su...
   Price 10.50 €
• Guidelines for the clinic...
   Price 12.00 €
• Far-advanced otosclerosis...
   Price 10.50 €
• Extramuscular soft tissue...
   Price 8.50 €
• Saddle nose surgery: Long...
   Price 10.50 €
• Complete branchial cleft ...
   Price 5.50 €
• The role of larynx kinest...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 8.50 €
• The application of tusso...
   Price 10.50 €
• Voice prostheses: long-te...
   Price 10.50 €
• Ambulatory stapedectomy: ...
   Price 8.50 €
• The ultra-low resistance ...
   Price 5.50 €
• Focus on the BPPV: Semont...
   Price 12.50 €
• How to manage post staped...
   Price 5.50 €
• Evaluation of the primary...
   Price 5.50 €
• Acoustic neuroma surgery....
   Price 10.50 €
• Long term results of KTP ...
   Price 5.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Vocal and behavioral adap...
   Price 10.50 €
• Bilateral paranasal sinus...
   Price 8.50 €
• Herniation of the temporo...
   Price 12.50 €
• Frontal sinus osteoma and...
   Price 5.50 €
• Interest of peri-operativ...
   Price 10.50 €
• Rhinoplasty: Advantages a...
   Price 10.50 €
• Trigeminal neuralgia: An ...
   Price 10.50 €
• Vocal rehabilitation with...
   Price 10.50 €
• Paediatric airway endosco...
   Price 5.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Functional septal surgery...
   Price 10.50 €
• The prevention of voice d...
   Price 10.50 €
• The Voice Handicap Index:...
   Price 10.50 €

Total Order 631.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2007 o

RHINOLOGY

Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis


Authors : Klossek J. M (Poitiers)

Ref. : Rev Laryngol Otol Rhinol. 2007;128,3:187-192.

Article published in french
Downloadable PDF document french



Summary : Sinusitis or acute rhinosinusitis, is defined as an acute viral or bacterial infection characterised by inflammation of the mucosa of the nose and paranasal sinuses. Although antibiotics are routinely prescribed for the treatment of acute sinusitis, most cases are caused by viral infections and will resolve without antibiotic therapy. Given concerns about global antibacterial resistance, evidence-based clinical practice guidelines recommend a conservative approach to antibiotic treatment, with mild or moderately severe acute sinusitis managed symptomatically. Intranasal corticosteroids act on the nasal mucosa to relieve inflammation and its associated symptoms, and may be a useful symptomatic treatment option. Two randomised, placebo-controlled trials have demonstrated that the corticosteroid mometasone furoate, administered as a nasal spray (MFNS), is effective as an adjunct to antibiotics in acute sinusitis. The design of these studies show a therapeutic approach known in Europe, but this attitude is still different from the current French guidelines. Furthermore, the efficacy and safety of MFNS monotherapy has been compared with antibiotic therapy in a randomised, double-blind, placebo-controlled trial in adults with acute uncomplicated sinusitis and probably viral. In this study, twice-daily (BID) MFNS 200 µg produced statistically greater improvements in overall symptoms and most individual symptoms compared with amoxicillin or placebo, even though Amoxicillin is not the one recommended by the French guidelines for this indication. These findings suggest that MFNS may play an important role in the management of acute sinusitis, either as monotherapy or as adjunctive treatment to antibiotics. These results lead also to think over its interest in the treatment of uncomplicated common forms of sinusitis, where antibiotics are still widely prescribed in daily practice.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE